Evidence map›Paper›PMID 37389951›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2023

More than just a small left ventricle: the right ventricular fibroblast and ECM in health and disease.

Benjamin D McNair, Samantha K Shorthill, Danielle R Bruns

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Right ventricular systolic function as a predictor of appropriate ICD therapy.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Article
  6. Cardiac fibroblasts: answering the call.American journal of physiology. Heart and circulatory physiology · 2024
    Review
  7. Article
  8. Article
  9. Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis.American journal of physiology. Heart and circulatory physiology · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Benjamin D McNairDivision of Kinesiology and Health, University of Wyoming, Laramie, Wyoming, United States.
Samantha K ShorthillDivision of Kinesiology and Health, University of Wyoming, Laramie, Wyoming, United States.
Danielle R BrunsDivision of Kinesiology and Health, University of Wyoming, Laramie, Wyoming, United States.ORCID 0000-0003-3066-111X
University of Wyoming · US

Funding

Therapeutic activation of AMPK for the aging right heartK01AG058810 · NIA · UNIVERSITY OF WYOMING · PI BRUNS, DANIELLE REULAND · 2019 to 2023
$805k
NIA NIH HHS K01 AG058810
6 · The paper itself

Abstract

Fibroblasts intricately organize and regulate the extracellular matrix (ECM) in cardiac health and disease. Excess deposition of ECM proteins causes fibrosis, resulting in disrupted signaling conduction and contributing to the development of arrhythmias and impaired cardiac function. Fibrosis is causally involved in cardiac failure in the left ventricle (LV). Fibrosis likely occurs in right ventricle (RV) failure, yet mechanisms remain unclear. Indeed, RV fibrosis is poorly understood with mechanisms often extrapolated from the LV to the RV. However, emerging data suggest that the LV and RV are distinct cardiac chambers and differ in regulation of the ECM and response to fibrotic stimuli. In the present review, we will discuss differences in ECM regulation in the healthy RV and LV. We will discuss the importance of fibrosis in the development of RV disease in pressure overload, inflammation, and aging. During this discussion, we will highlight mechanisms of fibrosis with respect to the synthesis of ECM proteins while acknowledging the importance of considering collagen breakdown. We will also discuss current knowledge of antifibrotic therapies in the RV and the need for additional research to help delineate the shared and distinct mechanisms of RV and LV fibrosis.

Indexed as

Heart FailureVentricular Dysfunction, RightExtracellular MatrixExtracellular Matrix ProteinsFibroblastsFibrosisHeart VentriclesHumansVentricular Function, RightExtracellular Matrix Proteinsagingfibroblastfibrosisright ventricle

Identifiers

PMID37389951
PMCPMC10396282
OpenAlexW4382678642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.